Search Results - "Viana, Thércia G."

  • Showing 1 - 9 results of 9
Refine Results
  1. 1

    Effects of JL13, a pyridobenzoxazepine compound, in dopaminergic and glutamatergic models of antipsychotic activity by Andrade, Yane C.P., Ropke, Jivago, Viana, Thércia G., Fanelli, Chiara, Minaldi, Elisa, Batista, Luara A., Issy, Ana C., Del Bel, Elaine A., Rodrigues, Lívia C.M., Liégeois, Jean-François, Moreira, Fabrício A.

    Published in Behavioural pharmacology (01-02-2021)
    “…The pyridobenzoxazepine compound, 5-(4-methylpiperazin-1-yl)-8-chloro-pyrido[2,3-b][1,5]benzoxazepine (JL13), has been developed as a potential antipsychotic…”
    Get full text
    Journal Article Web Resource
  2. 2

    Anti-aversive role of the endocannabinoid system in the periaqueductal gray stimulation model of panic attacks in rats by Viana, Thércia G., Hott, Sara C., Resstel, Leonardo B., Aguiar, Daniele C., Moreira, Fabrício A.

    Published in Psychopharmacology (01-05-2015)
    “…Rationale Direct activation of the cannabinoid CB1 receptor in the dorsolateral periaqueductal gray (dlPAG) inhibits anxiety- and panic-related behaviours in…”
    Get full text
    Journal Article
  3. 3

    Modeling panic disorder in rodents by Moreira, Fabrício A, Gobira, Pedro H, Viana, Thércia G, Vicente, Maria A, Zangrossi, Hélio, Graeff, Frederico G

    Published in Cell and tissue research (01-10-2013)
    “…Panic disorder (PD) is a subtype of anxiety disorder in which the core phenomenon is the spontaneous occurrence of panic attacks. Although studies with…”
    Get full text
    Journal Article
  4. 4

    Hypothalamic endocannabinoid signalling modulates aversive responses related to panic attacks by Viana, Thércia G., Bastos, Juliana R., Costa, Rayssa B., Hott, Sara C., Mansur, Frederico S., Coimbra, Cândido C., Resstel, Leonardo B., Aguiar, Daniele C., Moreira, Fabrício A.

    Published in Neuropharmacology (01-04-2019)
    “…Recurrent panic attacks, comprising emotional and cardiovascular aversive responses, are common features in panic disorder, a subtype of anxiety disorder. The…”
    Get full text
    Journal Article
  5. 5

    Effects of aripiprazole on caffeine-induced hyperlocomotion and neural activation in the striatum by Batista, Luara A., Viana, Thércia G., Silveira, Vívian T., Aguiar, Daniele C., Moreira, Fabrício A.

    “…Aripiprazole is an antipsychotic that acts as a partial agonist at dopamine D 2 receptors. In addition to its antipsychotic activity, this compound blocks the…”
    Get full text
    Journal Article
  6. 6

    Inhibition of endocannabinoid neuronal uptake and hydrolysis as strategies for developing anxiolytic drugs by Batista, Luara A, Gobira, Pedro H, Viana, Thercia G, Aguiar, Daniele C, Moreira, Fabricio A

    Published in Behavioural pharmacology (01-09-2014)
    “…The endocannabinoid system comprises the CB1 and CB2 receptors (the targets of the Cannabis sativa compound delta-9-tetrahydrocannabinol), the endogenous…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Effects of Aripiprazole, an Atypical Antipsychotic, on the Motor Alterations Induced by Acute Ethanol Administration in Mice by Viana, Thercia G., Almeida‐Santos, Ana F., Aguiar, Daniele C., Moreira, Fabricio A.

    Published in Basic & clinical pharmacology & toxicology (01-05-2013)
    “…Aripiprazole is an antipsychotic that acts as a partial agonist at dopamine receptors. As the effects of most drugs of abuse converge to enhance…”
    Get full text
    Journal Article
  9. 9